Jeffrey Kahn, director of the Bioethics Institute at Johns Hopkins University, said the move is consistent with recommendations from the Institute of Medicine several years ago. “We have mechanisms in place to protect patients,” he said. “It doesn’t need to be treated as a special case of clinical research any longer.”

Quick Read

People with multiple sclerosis sometimes become desperate and will travel to other countries for experimental stem cell treatments. That’s not always a good idea

Quick Read

“My signature was so bad, and my writing was just atrocious,” he says. “One day I was over at our business and I was writing an order. And one of my foremen said, ‘Why don’t you let me write that for you?’ “

Quick Read

The FDA is powerless to stop them. The newly enacted right-to-try law allows drug makers to earn a profit by selling unproven therapies to desperate and dying patients

Quick Read

Parents-to-be want to know. Every parent-to-be wants a healthy baby. And, when offered an opportunity, most couples want to know which disease-causing genes, or risk factors, they carry and could unwittingly pass to their children

Quick Read

They’re the tech-age version of donor jars at the diner: crowdfunding websites that aim to link ailing people with strangers willing to help pay for medical treatment. But new research suggests duped patients sometimes crowdfund to pay for bogus stem cell treatments.

Quick Read

Research shows that women overestimate their risk of cancer and overestimate the potential of dying of cancer. This anxiety may prompt women to seek aggressive interventions even when they do not have cancer

Quick Read

To improve health care, researchers need to study diseases as they occur: in combination

Quick Read